Navigation Links
Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future of Treatment for Chronic Lymphocytic Leukemia
Date:12/8/2013

NEW ORLEANS, Dec. 8, 2013 /PRNewswire-USNewswire/ -- Several new, targeted therapies show promise to expand treatment options for chronic lymphocytic leukemia (CLL) and are more effective and better tolerated than standard chemotherapy, according to studies presented today during the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans.

CLL is a blood cancer that occurs when abnormal white blood cells called lymphocytes accumulate in the blood, bone marrow, and lymph nodes or other organs, causing these organs to enlarge. Approximately 15,000 Americans are diagnosed with CLL every year, and nearly 70 percent of those affected are 65 or older. For some patients with a slower progressing disease, many physicians employ "watch and wait" strategies to minimize unnecessary toxic treatments. However, patients with high-risk features or a more rapidly progressing disease require prompt treatment.

While the current standard chemotherapy-based treatment regimen for patients with CLL has been effective in improving outcomes for these patients, it remains highly toxic, prompting additional research to identify strategies to further reduce the treatment burden. Newer drugs that more precisely target pathways and proteins known to trigger CLL development, and leave normal cells unharmed, are proving to be more effective in promoting cancer cell death while safer for the patient. Four studies presented today reveal data on the performance of several new CLL therapies that demonstrate potent effects on key regulators of cancer cell behavior.

"These exciting developments in CLL therapy represent a shift toward treatments that hone in on specific regulators of cancer, ultimately providing a safer and more effective treatment regimen," said Jennifer R. Brown, MD, PhD, Director of the Chronic Lymphocytic Leukemia Center at Dana-Farber Cancer Institute in
'/>"/>

SOURCE American Society of Hematology
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CMTC announces Physician Collaboration Platform ("PCP") Upgrade: A cloud-based telehealth solution for improved collaboration, access and performance
2. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
3. Data for Investigational Tiotropium Show Improved Lung Function and Sustained Bronchodilation in Patients with Moderate Asthma Severity
4. UHC to Launch New Specialty Pharmacy Program for Better Continuity of Patient Care, Improved Access to Specialty Pharmaceuticals
5. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
6. How Those with Diabetes Who Overindulge Can Chew Their Way to Improved Health
7. Large-Scale Kaiser Permanente Program Linked to Improved Blood Pressure Control
8. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
9. Ultra Solutions Debuts New Website Featuring Improved Navigability and Design
10. For Second- and Subsequent-Line Metastatic Castrate-Resistant Prostate Cancer, Surveyed Oncologists Indicate that Improved Symptom Control and Quality of Life is one of the Greatest Unmet Needs
11. Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 BioLight ... BLGTY) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, today announced that its ... identified several new genetic markers with high potential ... treated with bisphosphonate drugs and was able to ...
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
(Date:8/31/2015)... DUBLIN , Aug. 31, 2015 ... the addition of the "Prescription Pain Drugs ... Medical Marijuana - Global Markets, Competitors and Opportunities: ... to their offering. Pain is ... associated with actual or potential tissue damage. At ...
Breaking Medicine Technology:BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3
(Date:8/31/2015)... ... 2015 , ... The dental implant and prosthetic market in the U.S. is ... (See Press Room ) More than 30 million Americans are missing all their ... demand for dental implants, the National Association of Dental Laboratories (NADL) created the “What’s ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... psychology professor Luciana Lagana (aka Dr. Luciana) received a total of three ... Series, Best Documentary, and Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this ...
(Date:8/31/2015)... ... 2015 , ... People with hostile personality traits who watch ... potentially because they are more susceptible to the influence of television on violence ... discovered. , The research, published online in the International Journal of Injury ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Month 2015 in September by sharing the facts about the role of heredity ... and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions to have both ...
(Date:8/31/2015)... ... August 31, 2015 , ... Move over shave cream. Roll over ... barbershops are scrambling to meet it. , Reports published this year (Mintel data) announced ... But the data also reflects that men are getting more done at barbershops than ...
Breaking Medicine News(10 mins):Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3
... announces the launch of their new website www.GlaceComplete.com . ... to Glenwood Systems and the company,s turbo-charged practice management/billing system GlaceComplete ... information. , ... Waterbury, CT (PRWEB) January Monday 12, ...
... the popular salve used to relieve symptoms of cough ... New research appearing in the January issue of ... of Chest Physicians (ACCP), shows that Vicks VapoRub (VVR) ... have severe effects on breathing in an infant or ...
... QLT and Upholds District Court DecisionVANCOUVER, Jan. 12 /PRNewswire-FirstCall/ ... QLT) announced that the United States Court of Appeals ... affirmed the judgment of the United States District Court ... the lawsuit brought against QLT by Massachusetts Eye and ...
... Patient, Provider and Industry Groups Calls for CER ... of Health CareWASHINGTON, Jan. 12 Federally-supported comparative ... improve health care decision-making, and must be structured ... provider needs, according to the Partnership to Improve ...
... of the widely used guideline , , MONDAY, Jan. 12 (HealthDay News) ... who have a low 10-year risk of heart attack or stroke ... a high lifetime risk. , That,s the conclusion of a new ... It,s the third study published in the last week to question ...
... (NYSE: DGX ), the world,s leading provider ... it will report fourth-quarter and full year 2008 results ... 26, before the market opens. It will hold its ... beginning at 8:30 a.m. ET on that day.The public ...
Cached Medicine News:Health News:Glenwood Systems, LLC Launches New Website -- GlaceComplete.com 2Health News:Misuse of Vicks VapoRub may harm infants and toddlers 2Health News:Misuse of Vicks VapoRub may harm infants and toddlers 3Health News:QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation 2Health News:QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation 3Health News:PIPC Outlines CER Principles in Letter to President-Elect Obama 2Health News:PIPC Outlines CER Principles in Letter to President-Elect Obama 3Health News:PIPC Outlines CER Principles in Letter to President-Elect Obama 4Health News:Framingham Score May Not Spot Lifetime Heart Risk 2Health News:Framingham Score May Not Spot Lifetime Heart Risk 3Health News:Quest Diagnostics to Release Fourth Quarter and Full Year 2008 Financial Results 2
Silicone Elastomer-Coated Latex Foley Catheters 2-Way (Pediatric)...
Midstream Catch Kits...
Midstream Catch Kits...
... BVM 6500 enables physicians ... determine UEBW (ultrasound estimated ... volume using 3-dimensional V-mode ... was designed to assist ...
Medicine Products: